REATA PHARMACEUTICALS INC (RETA)
Institutional ownership reported to the SEC as of Q3 2023, across 20 quarters.
4
Reporting holders
$66.4M
Reported value
99.9%
Held as options
-194
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Maven Securities LTD | $66.4M | options only | 0.75% | new | OPTIONS |
| IFP Advisors, Inc | $51.7K | 300 | 0.00% | 13q | -50.0%-$51.7K |
| DekaBank Deutsche Girozentrale | $2.9K | 17,000 | 0.01% | 16q | HELD |
| SIMPLEX TRADING, LLC | $807 | options only | 0.00% | 20q | OPTIONS |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 4 | $66.4M | 17,300 | 2 | 0 | 1 | 99.9% |
| Q2 2023 | 198 | $3.1B | 29,155,756 | 36 | 65 | 52 | 5.1% |
| Q1 2023 | 181 | $2.7B | 26,553,058 | 57 | 35 | 56 | 11.5% |
| Q4 2022 | 146 | $1.1B | 28,304,616 | 39 | 43 | 35 | 4.4% |
| Q3 2022 | 158 | $780.5M | 28,106,401 | 32 | 39 | 43 | 9.5% |
| Q2 2022 | 143 | $864.3M | 27,754,991 | 17 | 42 | 43 | 2.5% |
| Q1 2022 | 150 | $978.0M | 27,050,494 | 29 | 36 | 43 | 9.3% |
| Q4 2021 | 152 | $744.9M | 26,771,075 | 26 | 44 | 41 | 5.2% |
| Q3 2021 | 190 | $2.8B | 26,688,077 | 19 | 67 | 52 | 4.8% |
| Q2 2021 | 202 | $3.8B | 26,542,134 | 34 | 62 | 68 | 2.2% |
| Q1 2021 | 204 | $2.6B | 25,265,458 | 33 | 74 | 52 | 2.8% |
| Q4 2020 | 203 | $3.1B | 24,733,196 | 41 | 66 | 62 | 2.6% |
| Q3 2020 | 190 | $2.2B | 22,168,280 | 27 | 67 | 66 | 3.2% |
| Q2 2020 | 215 | $3.8B | 23,228,723 | 39 | 70 | 65 | 3.3% |
| Q1 2020 | 219 | $3.5B | 22,646,026 | 31 | 77 | 73 | 5.4% |
| Q4 2019 | 222 | $4.8B | 22,668,093 | 64 | 78 | 47 | 4.0% |
| Q3 2019 | 169 | $1.5B | 18,223,313 | 29 | 63 | 35 | 4.9% |
| Q2 2019 | 161 | $1.7B | 17,647,276 | 28 | 59 | 47 | 3.7% |
| Q1 2019 | 159 | $1.4B | 16,564,601 | 39 | 46 | 45 | 1.5% |
| Q4 2018 | 135 | $912.5M | 16,139,816 | 4 | 1 | 1 | 0.8% |